A Multi-center, Randomized, Double-blind, Placebo-controlled, Phase IIa Clinical Trial to Evaluate the Safety and Explore the Efficacy of UN03 for Non-alcoholic Steatohepatitis (NASH) with Fibrosis
Latest Information Update: 31 Jul 2020
At a glance
- Drugs UN 03 (Primary)
- Indications Hepatic fibrosis; Non-alcoholic steatohepatitis
- Focus Adverse reactions
- 31 Jul 2020 New trial record